Revealing a cancer-associated fibroblast-based risk signature for pancreatic adenocarcinoma through single-cell and bulk RNA-seq analysis
Aging · 2024
DOI: 10.18632/aging.206043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Jing Ma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Cancer-Associated Fibroblasts, Single-Cell Analysis, Adenocarcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Zitieren
APA
Ma, J., Chen, Z., & Hou, L. (2024). Revealing a cancer-associated fibroblast-based risk signature for pancreatic adenocarcinoma through single-cell and bulk RNA-seq analysis. Aging. https://doi.org/10.18632/aging.206043
Vancouver
Ma J, Chen Z, Hou L. Revealing a cancer-associated fibroblast-based risk signature for pancreatic adenocarcinoma through single-cell and bulk RNA-seq analysis. Aging. 2024. doi:10.18632/aging.206043
BibTeX
@article{Ma2024,
author = {Ma, Jing and Chen, Zhinan and Hou, Limin},
title = {Revealing a cancer-associated fibroblast-based risk signature for pancreatic adenocarcinoma through single-cell and bulk RNA-seq analysis},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.206043}
}
EUVIMED